Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis
Annals of the Rheumatic DiseasesPublished 26 April 2016Open access
Jeffrey R. Curtis, Fenglong Xie, Huifeng Yun, Sasha Bernatsky, Kevin Winthrop
Citations277
SJR quartileQ1
SJR score5.73
SNIP4.44
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The rate of zoster associated with tofacitinib was approximately double that observed in patients using biologics, and a composite outcome of HZ or HSV.
Abstract
The rate of zoster associated with tofacitinib was approximately double that observed in patients using biologics.
Keywords
Medicine
EconometricaA Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity
26,139 Citations1980Halbert White
New England Journal of MedicinePlacebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
995 Citations2012Roy Fleischmann, Joel M. Kremer +8 more
In patients with active rheumatoid arthritis, tofacitinib monotherapy was associated with reductions in signs and symptoms of rheumatism and improvement in physical function and tofacit inib treatment wasassociated with elevations in low-density lipoprotein cholesterol levels and reductions in neutrophil counts.
New England Journal of MedicineTofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
915 Citations2012Ronald van Vollenhoven, Roy Fleischmann +12 more
In patients with rheumatoid arthritis receiving background methotrexate, tofacitinib was significantly superior to placebo and was numerically similar to adalimumab in efficacy.
Mayo Clinic ProceedingsA Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction
858 Citations2007Barbara P. Yawn, Patricia Saddier +4 more
The authors' population-based data suggest that HZ primarily affects immunocompetent adults older than 50 years; 1 in 4 experiences some type of HZ-related complication.
Archives of Internal MedicineThe Incidence of Herpes Zoster
621 Citations1995James G. Donahue
The recorded incidence of herpes zoster was 64% higher than that reported 30 years ago; the age-standardized rate was more than twofold higher and immunosuppressive conditions had little impact on overall incidence, although they were strongly associated with early recurrences.
Journal of Interferon & Cytokine ResearchInduction and Regulation of IFNs During Viral Infections
450 Citations2004Lene Malmgaard
IFN-alpha/beta and IFN-gamma affect activities of macrophages, NK cells, dendritic cells, and T cells by enhancing antigen presentation, cell trafficking, and cell differentiation and expression profiles, ultimately resulting in enhanced antiviral effector functions.
Arthritis & RheumatologyHerpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
350 Citations2014Kevin Winthrop, Hisashi Yamanaka +6 more
The aim of this study was to determine whether treatment with tofacitinib increases the risk of HZ in patients with RA.
The Journal of Infectious DiseasesDecline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine
320 Citations2003Myron J. Levin, Jeffrey G. Smith +14 more
A live attenuated VZV vaccine is safe and immunogenic in an elderly population, and the vaccine-induced immunity may be monitored by the IFN-gamma ELISPOT assay, which had greater sensitivity and a wider dynamic range.
Arthritis & RheumatismSerious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: Lessons from interpreting data from observational studies
306 Citations2007William G Dixon, Deborah Symmons +4 more
Arthritis Research & TherapyValidation of rheumatoid arthritis diagnoses in health care utilization data
234 Citations2011Seoyoung C. Kim, Amber Servi +5 more
To accurately identify RA patients in health care utilization databases, algorithms that include both diagnosis codes and DMARD prescriptions are recommended.
Arthritis & RheumatismThe JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon‐γ and interleukin‐17 production by human CD4+ T cells
231 Citations2011Keisuke Maeshima, Kunihiro Yamaoka +10 more
Tofacitinib directly suppressed the production of IL-17 and IFNγ and the proliferation of CD4+ T cells, resulting in inhibition ofIL-6 production by RASFs and IL-8 production by CD14+ cells and decreased cartilage destruction.
Arthritis & RheumatologyRisk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination
225 Citations2016Huifeng Yun, Shuo Yang +7 more
Evaluated the age‐stratified incidence of HZ in patients with AI diseases as compared to older adults for whom the HZ vaccine is currently recommended by the US Centers for Disease Control and Prevention.
Arthritis Care & ResearchSerious infections in a population‐based cohort of 86,039 seniors with rheumatoid arthritis
218 Citations2012Jessica Widdifield, Sasha Bernatsky +6 more
To assess risk and risk factors for serious infections in seniors with rheumatoid arthritis (RA) using a case–control study nested within an RA cohort, a cohort-based model is used.
Arthritis Care & ResearchRisks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease‐Modifying Therapy
118 Citations2014Huifeng Yun, Fenglong Xie +9 more
To evaluate whether the risks of herpes zoster differed by biologic agents with different mechanisms of action (MOAs) in older rheumatoid arthritis patients, a large number of patients were diagnosed with herpes Zoster.
Arthritis Care & ResearchHerpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease‐Modifying Antirheumatic Drugs
91 Citations2015Dimitrios A. Pappas, Michele Hooper +6 more
To identify the rheumatoid arthritis characteristics associated with increased herpes zoster risk in the Corrona registry RA patients, and to evaluate the risk in initiators of tumor necrosis factor inhibitors or non‐TNFi biologic agents, conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs) other than MTX are evaluated.
Journal of the American Geriatrics SocietyVariation in Prostate‐Specific Antigen Screening in Men Aged 80 and Older in Fee‐for‐Service Medicare
43 Citations2010Julie Bynum, Xue Song +1 more
To determine the rate of prostate‐specific antigen (PSA) screening in men aged 80 and older in Medicare and to examine geographic variation in screening rates across the U.S.
JNCI Journal of the National Cancer InstituteRacial and Ethnic Differences in Use of Mammography Between Medicare Advantage and Traditional Medicare
42 Citations2013John Z. Ayanian, Bruce E. Landon +2 more
Higher rates of mammography in HMOs and PPOs were associated with a reversal of racial and ethnic differences observed in traditional Medicare, which may be related to lower patient cost-sharing and better systems to promote preventive services in managed care plans.
Leukemia & lymphoma/Leukemia and lymphomaEfficacy and safety of ruxolitinib in Asian patients with myelofibrosis
30 Citations2014Chul Won Jung, Lee‐Yung Shih +26 more
Ruxolitinib was well tolerated in Asian patients with myelofibrosis and provided substantial reductions in splenomegaly and improvements in symptoms and adverse events were consistent with those seen in the COMFORT studies.
Clinical RheumatologyOccasional presence of herpes viruses in synovial fluid and blood from patients with rheumatoid arthritis and axial spondyloarthritis
16 Citations2015Rubén Burgos, Graciela Ordóñez +3 more
The results indicate the occasional presence of DNA from herpes viruses in patients with rheumatoid arthritis or with axial spondyloarthritis, but these findings might represent a parallel epiphenomenon of viral activation associated either with immunosuppressive therapy or with primary immune disturbances, rather than the etiological participation of herpes virus in these disorders.